FENC

Fennec Pharmaceuticals Inc

• TipRanks·2d ago

  Fennec Shareholders Approve Governance, Compensation and Equity Plans

• PUBT·2d ago

  Fennec Pharmaceuticals highlights new ASCO studies on PEDMARK use to prevent cisplatin-induced hearing loss

• PUBT·2d ago

  Fennec Pharmaceuticals held annual shareholder meeting, elected directors

• PUBT·06/02 20:07

  Fennec Pharmaceuticals director Rosty Raykov disposes of common shares worth $93,790.14

• TipRanks·05/22 21:01

  Fennec Showcases New PEDMARK Data at ASCO 2026

• TipRanks·05/22 15:40

  Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO)

• Dow Jones·05/22 11:00

  Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·05/22 11:00

  Fennec Pharmaceuticals Price Target Raised to $16.00/Share From $13.00 by HC Wainwright & Co.

• Benzinga·05/22 10:49

  HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $16

• TipRanks·05/22 10:17

  Fennec price target raised to $16 from $13 at H.C. Wainwright

• Reuters·05/22 10:10

  FENNEC PHARMACEUTICALS, INC. <FENC.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $16 FROM $13

• Reuters·05/22 06:49

  U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

• PUBT·05/21 22:01

  Fennec says Phase 1 PEDMARK trial in metastatic germ cell tumors opens for accrual

• PUBT·05/18 20:30

  Fennec grants 50,000 stock options to new hires at $9.75 per share

• Reuters·05/18 20:30

  FENNEC PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)